PATENT CLAIM ANALYSIS

Application Number: 16069201
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2019-01
Patent Classification: ["544", "272000"]

Abstract:
This disclosure features dinucleotide compounds that modulate Stimulator of Interferon Genes (STING) activity, for use for example in the treatment of cancer. This disclosure also features compositions as well as other methods of using and making the same. A and B are each independently selected from the group consisting of Formulae (i), (ii), (iii), and (iv):

Claim (Index 146):
A compound of Formula I: or a pharmaceutically acceptable salt thereof, wherein: A and B are each independently selected from the group consisting of Formulae (i), (ii), (iii), and (iv): X and X\u2032 are each independently selected from the group consisting of O, S, S(O), SO 2 , CH 2 , CHF, CF 2 , CH 2 O, OCH 2 , CH 2 CH 2 , CH\u2550CH, NR 3 , and N(O \u2212 )R 3 ; G 1  is a bond connecting (i) the carbon directly attached to X 2  and (ii) the carbon directly attached to C(R 2A )(R 2B )(X 6 ); or is C(R G1A )(R G1B ); G 2  is a bond connecting (i) the carbon directly attached to X 4  and (ii) the carbon directly attached to C(R 1A )(R 1B )(X 3 ); or is C(R G2A )(R G2B ); X 1  and X 5  are each independently selected from the group consisting of H, C 1-4  alkyl, C 1-4  haloalkyl, halo, \u2014CN, \u2014NO 2 , \u2014N 3 , \u2014OH, \u2014OR a1 , \u2014SH, \u2014SR a1 , \u2014C(O)H, \u2014C(O)R a1 , \u2014C(O)NR b1 R c1 , \u2014C(O)OH, \u2014C(O)OR a1 , \u2014OC(O)H, \u2014OC(O)R a1 , \u2014OC(O)NR b1 R c1 , \u2014C(\u2550NR c1 )NR b1 R c1 , \u2014NR d1 C(\u2550NR c1 )NR b1 R c1 , \u2014NR b1 R c1 , \u2014 + NR b2 R c2 R d2 , \u2014NR d1 C(O)H, \u2014NR d1 C(O)R a1 , \u2014NR d1 C(O)OR a1 , \u2014NR d1 C(O)NR b1 R c1 , \u2014NR d1 S(O)R a1 , \u2014NR d1 S(O) 2 R a1 , \u2014NR d1 S(O) 2 NR b1 R c1 , \u2014S(O)R a1 , \u2014S(O)NR b1 R c1 , \u2014S(O) 2 R a1 , and \u2014S(O) 2 NR b1 R c1 ; X 2 , X 3 , X 4  and X 6  are each independently selected from the group consisting of O and S; L 1  is L 2  is Y 1  and Y 2  are each independently selected from the group consisting of \u2014OH, \u2014OR a1 , O \u2212 , \u2014SH, \u2014SR a1 , S \u2212 ; and \u2014NR b1 R c1 ; R 1A  and R 1B  are each independently selected from the group consisting of H; halo; C 1-4  alkyl; C 1-4  haloalkyl; C 2-4  alkenyl; C 2-4  alkynyl; and C 3-5  cycloalkyl, which is optionally substituted with from 1-4 independently selected C 1-4  alkyl; or R 1A  and R 1B , together with the carbon atom to which each is attached, form a C 3-5  cycloalkyl or heterocyclyl, including from 4-5 ring atoms, wherein from 1-2 ring atoms are independently selected from the group consisting of nitrogen and oxygen, wherein the C 3-5  cycloalkyl or heterocyclyl ring can each be optionally substituted with from 1-4 independently selected C 1-4  alkyl; R 2A  and R 2B  are each independently selected from the group consisting of H; halo; C 1-4  alkyl; C 1-4  haloalkyl; C 2-4  alkenyl; C 2-4  alkynyl; and C 3-5  cycloalkyl, which is optionally substituted with from 1-4 independently selected C 1-4  alkyl; or R 2A  and R 2B , together with the carbon atom to which each is attached, form a C 3-5  cycloalkyl or heterocyclyl, including from 4-5 ring atoms, wherein from 1-2 ring atoms are independently selected from the group consisting of nitrogen and oxygen, wherein the C 3-5  cycloalkyl or heterocyclyl ring can each be optionally substituted with from 1-4 independently selected C 1-4  alkyl, Z 1  is N or C\u2014R 4 ; Z 1\u2032  is N or C\u2014H; Z 2  is N or C\u2014R 4\u2032 ; Z 2 \u2032 is N or C\u2014H; Z 3  is N\u2014R 3  or C\u2014R 4 ; each occurrence of R a1  is independently selected from the group consisting of:\n C 1-10  alkyl optionally substituted with from 1-3 R A ; \n C 1-10  haloalkyl optionally substituted with from 1-3 R A ; \n C 2-10  alkenyl optionally substituted with from 1-3 R B , \n C 2-10  alkynyl optionally substituted with from 1-3 R B , \n C 3-10  cycloalkyl optionally substituted with from 1-5 R C ; \n (C 3-10  cycloalkyl)-C 1-6  alkylene, wherein the alkylene serves as the point of attachment, and wherein the C 3-10  cycloalkyl optionally substituted with from 1-5 R C ; \n heterocyclyl, including from 3-10 ring atoms, wherein from 1-3 ring atoms are independently selected from the group consisting of nitrogen, oxygen and sulfur, and which is optionally substituted with from 1-5 R C ; \n (heterocyclyl)-C 1-6  alkylene, wherein the alkylene serves as the point of attachment, and wherein the heterocyclyl is optionally substituted with from 1-5 R C ; \n C 6-10  aryl optionally substituted with from 1-5 R D ; \n heteroaryl including from 5-10 ring atoms, wherein from 1-4 ring atoms are independently selected from the group consisting of nitrogen, oxygen and sulfur, and which is optionally substituted with from 1-5 R D ; and \n (heteroaryl)-C 1-6  alkylene, wherein the alkylene serves as the point of attachment, and wherein the heteroaryl is optionally substituted with from 1-5 R D ; \n each occurrence of R b1  and R c1  is independently selected from the group consisting of: H; R a1 ; \u2014C(O)H, \u2014C(O)R a1 , \u2014C(O)NR b3 R c3 , \u2014C(O)OR a1 , \u2014OC(O)H, \u2014C(\u2550NR e2 )NR b3 R c3 , \u2014NR d3 C(\u2550NR e2 ) NR b3 R c3 , \u2014NR b3 R c3 , \u2014S(O) 2 R a1 , and \u2014S(O) 2  NR b3 R c3 ; or R b1  and R c1  taken together with the nitrogen atom to which each is attached form a heterocyclyl, including from 3-10 ring atoms, wherein from 1-3 ring atoms are independently selected from the group consisting of nitrogen, oxygen and sulfur, and which is optionally substituted with from 1-5 R C ;\n each occurrence of R 3 , R d1 , and R e1  is independently selected from the group consisting of: H; R a1 ; \u2014C(O)H, \u2014C(O)R a1 , \u2014C(O)NR b3 R c3 , \u2014C(O)OR a1 , \u2014OC(O)H, \u2014C(\u2550NR e2 )NR b3 R c3 , \u2014NR d3 C(\u2550NR e2 )NR b3 R c3 , \u2014NR b3 R c3 , \u2014S(O)R a1 , \u2014S(O)NR b3 R c3 , \u2014S(O) 2 R a1 , and \u2014S(O) 2 NR b3 R c3 ; \n each occurrence of R b2 , R c2 , and R d2  is independently selected from the group consisting of: H and C 1-6  alkyl optionally substituted with from 1-2 R A ; \n each occurrence of R b3 , R c3 , R d3 , and R e2  is independently selected from the group consisting of: H; C 1-6  alkyl optionally substituted with from 1-2 R A ; \u2014SO 2 (C 1-6  alkyl), \u2014C(O)(C 1-6  alkyl), and \u2014C(O)O(C 1-6  alkyl); \n each occurrence of R G1A , R G1B , R G1A , R G1B , R 4 , R 4\u2032 , R 5 , R 6 , and R 6\u2032  is independently selected from the group consisting of : H; R a1 ; halo, \u2014CN, \u2014NO 2 , \u2014N 3 , \u2014OH, \u2014OR a1 , \u2014SH, \u2014SR a1 , \u2014C(O)H, \u2014C(O)R a1 , \u2014C(O) NR b1 R c1 , \u2014C(O)OH, \u2014C(O)OR a1 , \u2014OC(O)H, \u2014OC(O)R a1 , \u2014OC(O)NR b1 R c1 , \u2014C(\u2550NR e1 )NR b1 R c1 , \u2014NR d1 C(\u2550NR e1 )NR b1 R c1 , \u2014NR b1 R c1 , \u2014 + NR b2 R c2 R d2 , \u2014NR d1 C(O)H, \u2014NR d1 C(O)R a1 , \u2014NR c1 C(O)OR a1 , \u2014NR d1 C(O)NR b1 R c1 , \u2014NR d1 S(O)R a1 , \u2014NR d1 S(O) 2 R a1 , \u2014NR d1 S(O) 2 NR b1 R c1 , \u2014S(O)R a1 , \u2014S(O)NR b1 R c1 , \u2014S(O) 2 R a1 , and \u2014S(O) 2 NR b1 R c1 ; \n each occurrence of R A  is independently selected from the group consisting of: \u2014CN; \u2014OH; C 1-6  alkoxy; C 1-6  haloalkoxy; \u2014C(O)NRR\u2032, wherein R\u2032 and R\u2033 are each independently selected from H and C 1-4  alkyl; \u2014C(O)OH; \u2014C(O)O(C 1-6  alkyl); and \u2014NR\u2033R\u2032\u2033, wherein R\u2033 and R\u2032\u2033 are each independently selected from the group consisting of H, C 1-4  alkyl, \u2014SO 2 (C 1-6  alkyl), \u2014C(O)(C 1-6  alkyl), and \u2014C(O)O(C 1-6  alkyl); \n each occurrence of R B  is independently selected from the group consisting of: halo; \u2014CN; \u2014OH; C 1-6  alkoxy; C 1-6  haloalkoxy; \u2014C(O)NRR\u2032, wherein R\u2032 and R\u2033 are each independently selected from H and C 1-4  alkyl; \u2014C(O)OH; \u2014C(O)O(C 1-6  alkyl); and \u2014NR\u2033R\u2032\u2033, wherein R\u2033 and R\u2032\u2033 are each independently selected from the group consisting of H, C 1-4  alkyl, \u2014SO 2 (C 1-6  alkyl), \u2014C(O)(C 1-6  alkyl), and \u2014C(O)O(C 1-6  alkyl); ; \n each occurrence of R C  is independently selected from the group consisting of: C 1-6  alkyl; C 1-4  haloalkyl; halo; \u2014CN; \u2014OH; oxo; C 1-6  alkoxy; C 1-6  haloalkoxy; \u2014C(O)NRR\u2032, wherein R\u2032 and R\u2033 are each independently selected from H and C 1-4  alkyl; \u2014C(O)(C 1-6  alkyl); \u2014C(O)OH; \u2014C(O)O(C 1-6  alkyl); and \u2014NR\u2033R\u2032\u2033, wherein R\u2033 and R\u2032\u2033 are each independently selected from the group consisting of H, C 1-4  alkyl, \u2014SO 2 (C 1-6  alkyl), \u2014C(O)(C 1-6  alkyl), and \u2014C(O)O(C 1-6  alkyl); \n each occurrence of R D  is independently selected from the group consisting of:\n C 1-6  alkyl optionally substituted with from 1-2 substituents independently selected from the group consisting of: \u2014OH, C 1-4  alkoxy; C 1-4  haloalkoxy; \u2014NH 2 , \u2014NH(C 1-4  alkyl), and \u2014N(C 1-4  alkyl) 2 ; \n C 1-4  haloalkyl; \n C 2-4  alkenyl; \n C 2-4  alkynyl; \n halo; \n \u2014CN; \n \u2014NO 2 ; \n \u2014N 3 ; \n \u2014OH; \n C 1-6  alkoxy; \n C 1-6  haloalkoxy; \n \u2014C(O)NRR\u2032, wherein R\u2032 and R\u2033 are each independently selected from H and C 1-4  alkyl; \n \u2014SO 2 NRR\u2032, wherein R\u2032 and R\u2033 are each independently selected from H and C 1-4  alkyl; \n \u2014C(O)(C 1-6  alkyl); \n \u2014C(O)OH; \n \u2014C(O)O(C 1-6  alkyl); \n \u2014SO 2 (C 1-6  alkyl), \n \u2014NR\u2033R\u2032\u2033, wherein R\u2033 and R\u2032\u2033 are each independently selected from the group consisting of H, C 1-4  alkyl, \u2014SO 2 (C 1-6  alkyl), \u2014C(O)(C 1-6  alkyl), and \u2014C(O)O(C 1-6  alkyl); \n (C 3-10  cycloalkyl)-(CH 2 ) 0-2 , wherein the CH 2 , when present, serves as the point of attachment, and wherein the C 3-10  cycloalkyl is optionally substituted with from 1-5 independently selected C 1-4  alkyl; \n (heterocyclyl)-(CH 2 ) 0-2 , wherein the CH 2 , when present, serves as the point of attachment, and wherein the heterocyclyl is optionally substituted with from 1-5 independently selected C 1-4  alkyl; \n (phenyl)-(CH 2 ) 0-2 , wherein the CH 2 , when present, serves as the point of attachment, and wherein the phenyl is optionally substituted with from 1-5 substituents independently selected from halo, C 1-4  alkyl, \u2014CF 3 , \u2014OCH 3 , \u2014SCH 3 , \u2014OCF 3 , \u2014NO 2 , \u2014N 3 , \u2014NH 2 , \u2014NH(C 1-4  alkyl), \u2014N(C 1-4  alkyl) 2 , \u2014C(O)(C 1-4  alkyl), \u2014C(O)OH, \u2014C(O)O(C 1-4  alkyl), \u2014SO 2 (CH 3 ), and cyclopropyl; \n (heteroaryl)-(CH 2 ) 0-2 , wherein the CH 2 , when present, serves as the point of attachment, and wherein the phenyl is optionally substituted with from 1-5 substituents independently selected from halo, C 1-4  alkyl, \u2014CF 3 , \u2014OCH 3 , \u2014SCH 3 , \u2014OCF 3 , \u2014NO 2 , \u2014N 3 , \u2014NH 2 , \u2014NH(C 1-4  alkyl), \u2014N(C 1-4  alkyl) 2 , \u2014C(O)(C 1-4  alkyl), \u2014C(O)OH, \u2014C(O)O(C 1-4  alkyl), \u2014SO 2 (CH 3 ), and cyclopropyl; and \n \n wherein it is provided: \n (a) X 1  and X 5  cannot both be \u2014OH: \n (b) X 1  and X 5  cannot both be halo; in certain embodiments, when A and B are each independently selected from formula (1) and formula (ii), then X 1  and X 5  cannot both be halo; \n (c) X 1  and X 5  cannot both be \u2014OR a1  when each occurrence of R a1  is C 10  alkyl optionally substituted with from 1-3 R A ; \n (d) X 1  and X 5  cannot both be \u2014OR a1  when each occurrence of R a1  is heterocyclyl, including from 3-10 ring atoms, wherein from 1-3 ring atoms are independently selected from the group consisting of nitrogen, oxygen and sulfur, and which is optionally substituted with from 1-5 R C ; \n (e) X 1  and X 5  cannot both be \u2014OR a1  when each occurrence of R a1  is (heterocyclyl)-C 1-6  alkylene; in certain of these embodiments, the heterocyclyl, portion includes from 5-7 ring atoms; \n (f) X 1  and X 5  cannot both be \u2014OC(O)R a1  when each occurrence of R a1  is C 1-10  alkyl optionally substituted with from 1-3 R A ; \n (g) X 1  and X 5  cannot both be \u2014OC(O)R a1  when each occurrence of R a1  is C 6-10  aryl; and \n (h) when one of X 1  and X 5  is \u2014OH, then the other of X 1  and X 5  cannot be:\n halo; \n \u2014OC(O)NR b1 R c1 ; \n \u2014OC(O)R a1 ; or \n \u2014OR a1 .

Metadata:
- Claim Count in Document: 51.0
- Percentile: 95.0
- Lexical Diversity: 1.4898
- Patent Class: 544.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['12813148', '14403763', '14358606', '14324560', '15040475']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.779924984380924
- 35 USC 102 Novelty (BERT): 0.5123779677574513
- Combined Prediction Score: 0.7531702827185767
- Mean Citation Score: 274.031962
- Max Citation Score: 275.4618
- Similarity Product: 186.550518805325

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test